Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: codeine / iodine; iodine containing attending: chief complaint: back pain major surgical or invasive procedure: none history of present illness: pt is a 64 yo female w/ h/o lymphoma (), sacral fx (dx'd ), and spinal stenosis p/w back pain. pt has had worsening back pain since she fx'd her sacrum back in . it is around the buttock area and upper back of thighs bilat, goes down to ankles when she stands, and is worse on the left. pain is while attempting to sit or walk, when lying down on her l side. she cannot sit or walk. she has tried different pain management regimens including duragesic patch, percocet, and vicodin. d/c'd them because they are ineffective and is now only taking motrin and advil. pt also reports having "severe" diarrhoea since this am. she says she has gone "30 times." stools were loose at the beginning, but now more watery. no blood, malodor, unusual color noted. ate chocolate-covered raisins last night. denies abd pain, n/v, f/c. also denies cp, sob, dysuria, hematuria. in the ed, was afebrile. given some dilaudid for the pain. pelvic ct showed healing right pubic rami/anterior column and sacral frx's. past medical history: diffuse large b-cell lymphoma tx with chop, rituximab, xrt for bulky l inguinal disease l4-5 stenosis dm obesity gerd hypothyroidism glaucoma cad retinopathy neuropathy carpal tunnel syndrome torn rotator cuff s/p partial hip replacement social history: married. no tobacco or etoh. family history: cad dm physical exam: t 97.9 bp 149/52 hr 79 rr 16 sat 96%ra gen: obese, lying on l side, in nad heent: perrl. op clear. mmm. no lad. cv: rrr. no m/r/g pulm: cta - b abd: obese, soft, nt/nd back: mild ttp along midspine. no ttp in sacral region. no cvat. ext: no edema. neuro: a&ox3 pertinent results: 05:59pm glucose-52* urea n-19 creat-0.8 sodium-141 potassium-4.3 chloride-108 total co2-20* anion gap-17 05:59pm wbc-9.6 rbc-3.97* hgb-12.6 hct-36.6 mcv-92 mch-31.8 mchc-34.5 rdw-15.7* 05:59pm neuts-72.9* lymphs-17.5* monos-6.4 eos-1.3 basos-1.9 05:59pm plt count-282 ct pelvis w/o contrast healing right pubic rami/anterior column and sacral frx's 05:25am blood wbc-9.2 rbc-3.85* hgb-12.1 hct-35.1* mcv-91 mch-31.4 mchc-34.4 rdw-15.1 plt ct-268 05:25am blood plt ct-268 05:25am blood glucose-149* urean-13 creat-0.8 na-138 k-4.2 cl-96 hco3-31* angap-15 05:25am blood calcium-8.8 phos-3.6 mg-1.8 brief hospital course: 64 yo female w/ h/o lymphoma, sacral fx, and spinal stenosis p/w back pain. 1. back pain: her pain sxs are from the sacral fx that is thought to be pathologic xrt for her lymphoma. per ortho notes on , the fx should be in the process of healing now and her pain should be getting better. the ct today showed a healing fx. pt essentially here for better pain control. given motrin for her pain. good control while lying down but in a lot of pain when attempting to sit or stand. the pain service recommended oxycontin, oxycodone, tylenol, vioxx, and a muscle relaxant. she was discharged on that same regimen for her pain before without control. decision was made to have surgery and pt underwent a l3-s1 posterior spinal fusion on . during the procedure, the pt received a large amount of iv fluids and blood products resultsing in chf exacerbation and prolonged intubation as outlined below. pt's postop pain was initially controlled on a hydromorphone pca and then changed to percocet on . she had good pain control at the time of discharged. had been working with physical therapy. 2. diarrhea: unclear etiology of the diarrhoea. sent off o&p and c.diff assays x3. the results were negative. diarrhea has now resolved. 3. respiratory distress: pt received a large amount of blood products and iv fluids during her spinal surgery resulting in chf and inability to extubate. at that time, the patient was transferred to the medical service in the micu. in the micu, the pt was agressively diuresed with iv lasix. in addition, her bp was tightly controlled with a nitro drip, beta blocker, and acei. pt was extubated on following a good diuresis. her respiratory status continued to improve throughout the course and was stable on discharge. 4. chf: pt had a chf exacerbation following receiving a large amount of volume during surgery. a tte was done on which showed a normal lvef with diastolic dysfunction. pt was agressively diuresed following surgery until . at that time, there was no evidence of chf on cxr and she was becoming contracted on labs. at that time, goal was to keep the pt even. pt was continued on beta blocker, acei, and oral nitrate. 5. cad: pt has a history of cad with placement of stents. she had no evidence of ischemia during the hospitalization. pt was continued on beta blocker, acei, statin, and asa. 6. hypothyroidism: pt was continued on levothyroxine throughout the hospitalization. 7. type 2 dm: consult was obtained during the admission. the pt's insulin was adjusted as needed during the hospitalization according to her food intake and blood sugar levels. 8. id: pt spiked a temperature on . she was started on cefazolin emperically but found to have a left lower lobe infiltrate on cxr. it was unclear if this was pna or atalectasis. is was encouraged. cultures are negative to date. pt will complete a 10 day course of antibiotics. medications on admission: insulin asa 325 qd protonix 40 qd lisinopril 20 norvasc 5 qd atenolol 50 qd lipitor 20 qd lasix 40 qd isosorbide 30 qd synthroid 150mcg qd betopic eye drops xalantin calcium 630 b12 mcg qd vitamic c 1000 folate discharge medications: 1. aspirin 325 mg tablet sig: one (1) tablet po qd (once a day). 2. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 3. multivitamin capsule sig: one (1) cap po qd (once a day). disp:*30 cap(s)* refills:*2* 4. folic acid 1 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 5. calcium carbonate 500 mg tablet, chewable sig: one (1) tablet, chewable po bid (2 times a day). disp:*60 tablet, chewable(s)* refills:*2* 6. cholecalciferol (vitamin d3) 400 unit tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 7. levothyroxine sodium 150 mcg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 8. ascorbic acid 500 mg tablet sig: two (2) tablet po bid (2 times a day). disp:*120 tablet(s)* refills:*2* 9. atorvastatin calcium 20 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 10. betaxolol hcl 0.25 % drops, suspension sig: one (1) drop ophthalmic qam (once a day (in the morning)). disp:*2 bottle* refills:*2* 11. latanoprost 0.005 % drops sig: one (1) drop ophthalmic hs (at bedtime). disp:*2 bottle* refills:*2* 12. isosorbide mononitrate 30 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po qd (once a day). disp:*30 tablet sustained release 24hr(s)* refills:*2* 13. cyanocobalamin 500 mcg tablet sig: two (2) tablet po bid (2 times a day). disp:*120 tablet(s)* refills:*2* 14. nph and humalog insulin- being titrated by blood sugars disp:*60 tablet(s)* refills:*0* 15. acetaminophen 500 mg capsule sig: two (2) capsule po every eight (8) hours. disp:*30 capsule(s)* refills:*2* 16. rofecoxib 12.5 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 17. cyclobenzaprine hcl 10 mg tablet sig: 0.5 tablet po tid (3 times a day). disp:*45 tablet(s)* refills:*2* 18. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 19. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 20. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po qd prn. disp:*20 tablet, delayed release (e.c.)(s)* refills:*2* 21. lisinopril 20 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 22. metoprolol tartrate 25 mg tablet sig: 1.5 tablets po tid (3 times a day). disp:*135 tablet(s)* refills:*2* 23. bacitracin zinc 500 unit/g ointment sig: one (1) appl topical (2 times a day). disp:*1 tube* refills:*2* 24. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed: hold for sedation or rr <12. disp:*30 tablet(s)* refills:*0* 25. furosemide 40 mg tablet sig: one (1) tablet po qd (once a day). disp:*30 tablet(s)* refills:*2* 26. cephalexin 500 mg tablet sig: one (1) tablet po q6h (every 6 hours) for 4 days. disp:*16 tablet(s)* refills:*0* discharge disposition: extended care facility: - discharge diagnosis: primary diagnosis: sacral fracture with l4-5 stenosis. underwent l3-s1 posterior fusion. chf exacerbation secondary diagnosis: diffuse large b-cell lymphoma diabetes mellitus obesity gerd hypothyroidism glaucoma coronary artery disease retinopathy neuropathy discharge condition: stable discharge instructions: 1. please take all medications as prescribed. 2. please keep all follow up appointments. 3. please seek medical attention if you experience worsening back pain, diarrhea, chest pain, shortness of breath, or temperature >101.4. contact your doctor for any symptoms you find concerning. followup instructions: 1. please follow up with dr. within one week of being discharged from the rehab facility. 2. please follow up with dr. in ortho spine clinic in two weeks as he has arranged with you. 3. provider: scan where: radiology phone: date/time: 11:15 4. provider: , md where: hematology/oncology phone: date/time: 10:00 procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours lumbar and lumbosacral fusion of the anterior column, posterior technique other exploration and decompression of spinal canal excision of intervertebral disc transfusion of packed cells open reduction of fracture with internal fixation, other specified bone transfusion of other serum insertion of interbody spinal fusion device fusion or refusion of 2-3 vertebrae diagnoses: congestive heart failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure effects of radiation, unspecified pathologic fracture of other specified site acquired spondylolisthesis 

Answer: The patient is high likely exposed to